{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:46:27Z","timestamp":1781333187373,"version":"3.54.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000275","name":"Leverhulme Trust","doi-asserted-by":"publisher","award":["RPG-2017-255"],"award-info":[{"award-number":["RPG-2017-255"]}],"id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10822-020-00356-4","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:15:37Z","timestamp":1603671337000},"page":"195-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-2986","authenticated-orcid":false,"given":"Giuseppe","family":"Deganutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Prischi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"356_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1473-3099(20)30293-0","volume":"20","author":"MS Xydakis","year":"2020","unstructured":"Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C, Herman P, Manley GT, Lyon DM, Hopkins C (2020) Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis 20:1015\u20131016. https:\/\/doi.org\/10.1016\/S1473-3099(20)30293-0","journal-title":"Lancet Infect Dis"},{"key":"356_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"356_CR3","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433. https:\/\/doi.org\/10.1016\/j.jaut.2020.102433","journal-title":"J Autoimmun"},{"key":"356_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/jmv.25689","volume":"92","author":"W Wang","year":"2020","unstructured":"Wang W, Tang J, Wei F (2020) Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 92:441\u2013447. https:\/\/doi.org\/10.1002\/jmv.25689","journal-title":"J Med Virol"},{"key":"356_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 3:237\u2013261. https:\/\/doi.org\/10.1146\/annurev-virology-110615-042301","journal-title":"Annu Rev Virol"},{"key":"356_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 1282:1\u201323. https:\/\/doi.org\/10.1007\/978-1-4939-2438-7_1","journal-title":"Methods Mol Biol"},{"key":"356_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/0042-6822(82)90095-2","volume":"119","author":"AR Collins","year":"1982","unstructured":"Collins AR, Knobler RL, Powell H, Buchmeier MJ (1982) Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell\u2013cell fusion. Virology 119:358\u2013371. https:\/\/doi.org\/10.1016\/0042-6822(82)90095-2","journal-title":"Virology"},{"key":"356_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","volume":"35","author":"F Jiang","year":"2020","unstructured":"Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z (2020) Review of the clinical characteristics of Coronavirus disease 2019 (COVID-19). J Gen Intern Med 35:1545\u20131549. https:\/\/doi.org\/10.1007\/s11606-020-05762-w","journal-title":"J Gen Intern Med"},{"key":"356_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0042-6822(90)90257-r","volume":"176","author":"S Abraham","year":"1990","unstructured":"Abraham S, Kienzle TE, Lapps W, Brian DA (1990) Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site. Virology 176:296\u2013301. https:\/\/doi.org\/10.1016\/0042-6822(90)90257-r","journal-title":"Virology"},{"key":"356_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, P\u00f6hlmann S (2020) A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell 78:779-784.e5. https:\/\/doi.org\/10.1016\/j.molcel.2020.04.022","journal-title":"Mol Cell"},{"key":"356_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181:281-292.e6. https:\/\/doi.org\/10.1016\/j.cell.2020.02.058","journal-title":"Cell"},{"key":"356_CR12","doi-asserted-by":"publisher","first-page":"256294","DOI":"10.1155\/2012\/256294","volume":"2012","author":"C Tikellis","year":"2012","unstructured":"Tikellis C, Thomas MC (2012) Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012:256294. https:\/\/doi.org\/10.1155\/2012\/256294","journal-title":"Int J Pept"},{"key":"356_CR13","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.res.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ Res 87:E1-9. https:\/\/doi.org\/10.1161\/01.res.87.5.e1","journal-title":"Circ Res"},{"key":"356_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","volume":"9","author":"M-Y Li","year":"2020","unstructured":"Li M-Y, Li L, Zhang Y, Wang X-S (2020) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 9:45. https:\/\/doi.org\/10.1186\/s40249-020-00662-x","journal-title":"Infect Dis Poverty"},{"key":"356_CR15","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2020-0147","author":"S Joshi","year":"2020","unstructured":"Joshi S, Joshi M, Degani MS (2020) Tackling SARS-CoV-2: proposed targets and repurposed drugs. Future Med Chem. https:\/\/doi.org\/10.4155\/fmc-2020-0147","journal-title":"Future Med Chem"},{"key":"356_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.06.017","author":"V Tiwari","year":"2020","unstructured":"Tiwari V, Beer JC, Sankaranarayanan NV, Swanson-Mungerson M, Desai UR (2020) Discovering small-molecule therapeutics against SARS-CoV-2. Drug Discov Today. https:\/\/doi.org\/10.1016\/j.drudis.2020.06.017","journal-title":"Drug Discov Today"},{"key":"356_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1021\/acsmedchemlett.0c00233","volume":"11","author":"J Whisenant","year":"2020","unstructured":"Whisenant J, Burgess K (2020) Blocking Coronavirus 19 infection via the SARS-CoV-2 spike protein: initial steps. ACS Med Chem Lett 11:1076\u20131078. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00233","journal-title":"ACS Med Chem Lett"},{"key":"356_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00502","author":"S Xiu","year":"2020","unstructured":"Xiu S, Dick A, Ju H, Mirzaie S, Abdi F, Cocklin S, Zhan P, Liu X (2020) Inhibitors of SARS-CoV-2 entry: current and future opportunities. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00502","journal-title":"J Med Chem"},{"key":"356_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, Zhang Z, Fan P, Dong Y, Yang Y, Chen Z, Guo Y, Zhang J, Li Y, Song X, Chen Y, Xia L, Fu L, Hou L, Xu J, Yu C, Li J, Zhou Q, Chen W (2020) A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science 369:650\u2013655. https:\/\/doi.org\/10.1126\/science.abc6952","journal-title":"Science"},{"key":"356_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto D, Park Y-J, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Telenti A, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D (2020) Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583:290\u2013295. https:\/\/doi.org\/10.1038\/s41586-020-2349-y","journal-title":"Nature"},{"key":"356_CR21","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Li W, Drabek D, Okba NMA, van Haperen R, Osterhaus ADME, van Kuppeveld FJM, Haagmans BL, Grosveld F, Bosch B-J (2020) A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11:2251. https:\/\/doi.org\/10.1038\/s41467-020-16256-y","journal-title":"Nat Commun"},{"key":"356_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.071","author":"Y Chen","year":"2020","unstructured":"Chen Y, Guo Y, Pan Y, Zhao ZJ (2020) Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.071","journal-title":"Biochem Biophys Res Commun"},{"key":"356_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.antiviral.2005.10.005","volume":"69","author":"T-Y Ho","year":"2006","unstructured":"Ho T-Y, Wu S-L, Chen J-C, Wei Y-C, Cheng S-E, Chang Y-H, Liu H-J, Hsiang C-Y (2006) Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 69:70\u201376. https:\/\/doi.org\/10.1016\/j.antiviral.2005.10.005","journal-title":"Antiviral Res"},{"key":"356_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581:215\u2013220. https:\/\/doi.org\/10.1038\/s41586-020-2180-5","journal-title":"Nature"},{"key":"356_CR25","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367:1444\u20131448. https:\/\/doi.org\/10.1126\/science.abb2762","journal-title":"Science"},{"key":"356_CR26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","volume":"160","author":"TKW Ma","year":"2010","unstructured":"Ma TKW, Kam KKH, Yan BP, Lam Y-Y (2010) Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 160:1273\u20131292. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00750.x","journal-title":"Br J Pharmacol"},{"key":"356_CR27","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1681\/ASN.2006040356","volume":"17","author":"C R\u00fcster","year":"2006","unstructured":"R\u00fcster C, Wolf G (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17:2985\u20132991. https:\/\/doi.org\/10.1681\/ASN.2006040356","journal-title":"J Am Soc Nephrol"},{"key":"356_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15094","author":"SPH Alexander","year":"2020","unstructured":"Alexander SPH, Armstrong J, Davenport AP, Davies J, Faccenda E, Harding SD, Levi-Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding MJ (2020) A rational roadmap for SARS-CoV-2\/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.15094","journal-title":"Br J Pharmacol"},{"key":"356_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"key":"356_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B 10:766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"356_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-020-00546-9","author":"S Mahdian","year":"2020","unstructured":"Mahdian S, Ebrahim-Habibi A, Zarrabi M (2020) Drug repurposing using computational methods to identify therapeutic options for COVID-19. J Diabetes Metab Disord. https:\/\/doi.org\/10.1007\/s40200-020-00546-9","journal-title":"J Diabetes Metab Disord"},{"key":"356_CR32","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12324980.v1","author":"CS Sharanya","year":"2020","unstructured":"Sharanya CS, Gangadharan AK, Jayanandhan A, Abdulhameed S, Madathilkovilakathu H (2020) Drug repurposing for COVID-19 from FDA approved and experiment stage drugs by in silico methods with SARS CoV-2 spike protein. J Biomol Struct Dyn. https:\/\/doi.org\/10.26434\/chemrxiv.12324980.v1","journal-title":"J Biomol Struct Dyn"},{"key":"356_CR33","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12032712.v2","author":"S Durdagi","year":"2020","unstructured":"Durdagi S, Aksoydan B, Dogan B, Sahin K, Shahraki A, Birg\u00fcl-\u0130yison N (2020) Screening of clinically approved and investigation drugs as potential inhibitors of SARS-CoV-2 main protease and spike receptor-binding domain bound with ACE2 COVID19 target proteins: a virtual drug repurposing study. J Biomol Struct Dyn. https:\/\/doi.org\/10.26434\/chemrxiv.12032712.v2","journal-title":"J Biomol Struct Dyn"},{"key":"356_CR34","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-24586\/v1","author":"A Trezza","year":"2020","unstructured":"Trezza A, Iovinelli D, Prischi F, Santucci A, Spiga O (2020) An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors. Sci Rep. https:\/\/doi.org\/10.21203\/rs.3.rs-24586\/v1","journal-title":"Sci Rep"},{"key":"356_CR35","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12292514.v1","author":"V Chandel","year":"2020","unstructured":"Chandel V, Sharma PP, Raj S, Rathi B, Kumar D (2020) Structure based drug repurposing through targeting Nsp9 replicase and spike proteins of SARS-CoV-2. J Biomol Struct Dyn. https:\/\/doi.org\/10.26434\/chemrxiv.12292514.v1","journal-title":"J Biomol Struct Dyn"},{"key":"356_CR36","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fimmu.2020.01664","volume":"11","author":"S Choudhary","year":"2020","unstructured":"Choudhary S, Malik YS, Tomar S (2020) Identification of SARS-CoV-2 cell entry inhibitors by drug repurposing using in silico structure-based virtual screening approach. Front Immunol 11:1664. https:\/\/doi.org\/10.3389\/fimmu.2020.01664","journal-title":"Front Immunol"},{"key":"356_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1021\/acs.jcim.5b00702","volume":"56","author":"A Cuzzolin","year":"2016","unstructured":"Cuzzolin A, Sturlese M, Deganutti G, Salmaso V, Sabbadin D, Ciancetta A, Moro S (2016) Deciphering the complexity of ligand-protein recognition pathways using supervised molecular dynamics (SuMD) simulations. J Chem Inf Model 56:687\u2013705. https:\/\/doi.org\/10.1021\/acs.jcim.5b00702","journal-title":"J Chem Inf Model"},{"key":"356_CR38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.9b01094","author":"G Deganutti","year":"2020","unstructured":"Deganutti G, Moro S, Reynolds CA (2020) A supervised molecular dynamics approach to unbiased ligand-protein unbinding. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.9b01094","journal-title":"J Chem Inf Model"},{"key":"356_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/ci400766b","volume":"54","author":"D Sabbadin","year":"2014","unstructured":"Sabbadin D, Moro S (2014) Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale. J Chem Inf Model 54:372\u2013376. https:\/\/doi.org\/10.1021\/ci400766b","journal-title":"J Chem Inf Model"},{"key":"356_CR40","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665\u2013W667. https:\/\/doi.org\/10.1093\/nar\/gkh381","journal-title":"Nucleic Acids Res"},{"key":"356_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson MHM, S\u00f8ndergaard CR, Rostkowski M, Jensen JH (2011) PROPKA3: consistent treatment of internal and surface residues in empirical pK predictions. J Chem Theory Comput 7:525\u2013537. https:\/\/doi.org\/10.1021\/ct100578z","journal-title":"J Chem Theory Comput"},{"key":"356_CR42","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11:3696\u20133713. https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","journal-title":"J Chem Theory Comput"},{"key":"356_CR43","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"key":"356_CR44","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1021\/ct9000685","volume":"5","author":"MJ Harvey","year":"2009","unstructured":"Harvey MJ, Giupponi G, Fabritiis GD (2009) ACEMD: accelerating biomolecular dynamics in the microsecond time scale. J Chem Theory Comput 5:1632\u20131639. https:\/\/doi.org\/10.1021\/ct9000685","journal-title":"J Chem Theory Comput"},{"key":"356_CR45","volume-title":"SHAKE, rattle, and roll: efficient constraint algorithms for linked rigid bodies","author":"TR Forester","year":"1998","unstructured":"Forester TR, Smith W (1998) SHAKE, rattle, and roll: efficient constraint algorithms for linked rigid bodies. J. Comput, Chem"},{"key":"356_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler V, van Gunsteren WF, H\u00fcnenberger PH (2001) A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem 22:501\u2013508. https:\/\/doi.org\/10.1002\/1096-987X(20010415)22:5%3c501::AID-JCC1021%3e3.0.CO;2-V","journal-title":"J Comput Chem"},{"key":"356_CR47","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577. https:\/\/doi.org\/10.1063\/1.470117","journal-title":"J Chem Phys"},{"key":"356_CR48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/bioinformatics\/btp036","volume":"25","author":"R Brenke","year":"2009","unstructured":"Brenke R, Kozakov D, Chuang G-Y, Beglov D, Hall D, Landon MR, Mattos C, Vajda S (2009) Fragment-based identification of druggable \u201chot spots\u201d of proteins using Fourier domain correlation techniques. Bioinformatics 25:621\u2013627. https:\/\/doi.org\/10.1093\/bioinformatics\/btp036","journal-title":"Bioinformatics"},{"key":"356_CR49","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nprot.2015.043","volume":"10","author":"D Kozakov","year":"2015","unstructured":"Kozakov D, Grove LE, Hall DR, Bohnuud T, Mottarella SE, Luo L, Xia B, Beglov D, Vajda S (2015) The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat Protoc 10:733\u2013755. https:\/\/doi.org\/10.1038\/nprot.2015.043","journal-title":"Nat Protoc"},{"key":"356_CR50","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/bioinformatics\/btx350","volume":"33","author":"J Jim\u00e9nez","year":"2017","unstructured":"Jim\u00e9nez J, Doerr S, Mart\u00ednez-Rosell G, Rose AS, De Fabritiis G (2017) DeepSite: protein-binding site predictor using 3D-convolutional neural networks. Bioinformatics 33:3036\u20133042. https:\/\/doi.org\/10.1093\/bioinformatics\/btx350","journal-title":"Bioinformatics"},{"key":"356_CR51","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.11847381.v1","author":"A Contini","year":"2020","unstructured":"Contini A (2020) Virtual screening of an FDA approved drugs database on two COVID-19 Coronavirus proteins. Life Sci. https:\/\/doi.org\/10.26434\/chemrxiv.11847381.v1","journal-title":"Life Sci"},{"key":"356_CR52","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"356_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"356_CR54","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17:490\u2013519. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199604)17:5\/6%3c490::AID-JCC1%3e3.0.CO;2-P","journal-title":"J Comput Chem"},{"key":"356_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"356_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247\u2013260. https:\/\/doi.org\/10.1016\/j.jmgm.2005.12.005","journal-title":"J Mol Graph Model"},{"key":"356_CR57","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"issue":"33\u20138","key":"356_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(33\u20138):27. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"356_CR59","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","journal-title":"J Chem Theory Comput"},{"key":"356_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-020-00338-6","author":"S Atanasio","year":"2020","unstructured":"Atanasio S, Deganutti G, Reynolds CA (2020) Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-020-00338-6","journal-title":"J Comput Aided Mol Des"},{"key":"356_CR61","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O\u2019Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, H\u00fcttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang X-P, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O\u2019Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang H-Y, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d\u2019Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, Garc\u00eda-Sastre A, Shokat KM, Shoichet BK, Krogan NJ (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459\u2013468. https:\/\/doi.org\/10.1038\/s41586-020-2286-9","journal-title":"Nature"},{"key":"356_CR62","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1021\/ci200117n","volume":"51","author":"SE Nichols","year":"2011","unstructured":"Nichols SE, Baron R, Ivetac A, McCammon JA (2011) Predictive power of molecular dynamics receptor structures in virtual screening. J Chem Inf Model 51:1439\u20131446. https:\/\/doi.org\/10.1021\/ci200117n","journal-title":"J Chem Inf Model"},{"key":"356_CR63","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fphar.2018.00923","volume":"9","author":"V Salmaso","year":"2018","unstructured":"Salmaso V, Moro S (2018) Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview. Front Pharmacol 9:923. https:\/\/doi.org\/10.3389\/fphar.2018.00923","journal-title":"Front Pharmacol"},{"key":"356_CR64","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1021\/jm00258a017","volume":"17","author":"H Nomura","year":"1974","unstructured":"Nomura H, Fugono T, Hitaka T, Minami I, Azuma T, Morimoto S, Masuda T (1974) Semisynthetic beta-lactam antibiotics. 6. 1 Sulfocephalosporins and their antipseudomonal activities. J Med Chem 17:1312\u20131315. https:\/\/doi.org\/10.1021\/jm00258a017","journal-title":"J Med Chem"},{"key":"356_CR65","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"356_CR66","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00754-20","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Schroeder S, Kleine-Weber H, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00754-20","journal-title":"Antimicrob Agents Chemother"},{"key":"356_CR67","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1099\/jgv.0.001047","volume":"99","author":"JM Sisk","year":"2018","unstructured":"Sisk JM, Frieman MB, Machamer CE (2018) Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. J Gen Virol 99:619\u2013630. https:\/\/doi.org\/10.1099\/jgv.0.001047","journal-title":"J Gen Virol"},{"key":"356_CR68","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1128\/JVI.01429-16","volume":"90","author":"CM Coleman","year":"2016","unstructured":"Coleman CM, Sisk JM, Mingo RM, Nelson EA, White JM, Frieman MB (2016) Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and middle east respiratory syndrome coronavirus fusion. J Virol 90:8924\u20138933. https:\/\/doi.org\/10.1128\/JVI.01429-16","journal-title":"J Virol"},{"key":"356_CR69","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","volume":"58","author":"J Dyall","year":"2014","unstructured":"Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB (2014) Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 58:4885\u20134893. https:\/\/doi.org\/10.1128\/AAC.03036-14","journal-title":"Antimicrob Agents Chemother"},{"key":"356_CR70","first-page":"107","volume":"40","author":"JL Claghorn","year":"1979","unstructured":"Claghorn JL, Mathew RJ, Mirabi M (1979) Penfluridol: a long acting oral antipsychotic drug. J Clin Psychiatry 40:107\u2013109","journal-title":"J Clin Psychiatry"},{"key":"356_CR71","doi-asserted-by":"publisher","first-page":"e1004166","DOI":"10.1371\/journal.ppat.1004166","volume":"10","author":"A Lundin","year":"2014","unstructured":"Lundin A, Dijkman R, Bergstr\u00f6m T, Kann N, Adamiak B, Hannoun C, Kindler E, J\u00f3nsd\u00f3ttir HR, Muth D, Kint J, Forlenza M, M\u00fcller MA, Drosten C, Thiel V, Trybala E (2014) Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog 10:e1004166. https:\/\/doi.org\/10.1371\/journal.ppat.1004166","journal-title":"PLoS Pathog"},{"key":"356_CR72","first-page":"471","volume-title":"To market, to market\u20142012","author":"J Bronson","year":"2013","unstructured":"Bronson J, Black A, Dhar TGM, Ellsworth BA, Merritt JR (2013) To market, to market\u20142012. Elsevier, Amsterdam, pp 471\u2013546"},{"key":"356_CR73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1021\/ci400532b","volume":"54","author":"D Sabbadin","year":"2014","unstructured":"Sabbadin D, Ciancetta A, Moro S (2014) Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A2 A adenosine receptor as a key study. J Chem Inf Model 54:169\u2013183. https:\/\/doi.org\/10.1021\/ci400532b","journal-title":"J Chem Inf Model"},{"key":"356_CR74","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/106002808602001104","volume":"20","author":"DB Wright","year":"1986","unstructured":"Wright DB (1986) Cefsulodin. Drug Intell Clin Pharm 20:845\u2013849. https:\/\/doi.org\/10.1177\/106002808602001104","journal-title":"Drug Intell Clin Pharm"},{"key":"356_CR75","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-29443\/v1","author":"GN Brooke","year":"2020","unstructured":"Brooke GN, Prischi F (2020) Structural and functional modelling of SARS-CoV-2 entry in animal models. Sci Rep. https:\/\/doi.org\/10.21203\/rs.3.rs-29443\/v1","journal-title":"Sci Rep"},{"key":"356_CR76","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1021\/acs.jpclett.0c01148","volume":"11","author":"A Spinello","year":"2020","unstructured":"Spinello A, Saltalamacchia A, Magistrato A (2020) Is the rigidity of SARS-CoV-2 spike receptor-binding motif the hallmark for its enhanced infectivity? insights from all-atom simulations. J Phys Chem Lett 11:4785\u20134790. https:\/\/doi.org\/10.1021\/acs.jpclett.0c01148","journal-title":"J Phys Chem Lett"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-020-00356-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-020-00356-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-020-00356-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T20:39:33Z","timestamp":1635194373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-020-00356-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1007\/s10822-020-00356-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-64722\/v1","asserted-by":"object"}]},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}